Global Negative Pressure Wound Therapy (NPWT) Market Report 2022: Market to Reach $3.1 Billion by 2026 - Hybrid Negative Pressure Wound Therapy (hNPWT) Widens Growth Prospects

2022-07-22 18:58:48 By : Ms. Susan Song

DUBLIN , May 20, 2022 /PRNewswire/ -- The "Negative Pressure Wound Therapy (NPWT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Negative Pressure Wound Therapy (NPWT) Market to Reach US$3.1 Billion by the Year 2026

The global market for Negative Pressure Wound Therapy (NPWT) estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2026, growing at a CAGR of 6.1% over the analysis period.

Negative pressure wound therapy represents an exciting advancement in wound care space that holds a number of clinical applications.

The global market for NPWT devices is on a growth path, on account of the rising incidence of chronic diseases including diabetes, and increasing surgical procedures. Diabetes entails the risk of causing diabetic foot ulcers and its treatment might require the use of NPWT devices. Similarly, immobility for long periods can lead to pressure ulcers, the treatment of which might need the use of NPWT devices.

Also, the expanding aging population suffering from various diseases which restrict their mobility bodes well for the demand for NPWT devices. Government efforts for the prevention of SSIs, and the increasing caesarean section procedures among older mothers are also fostering the use of NPWT devices (post-operative). The availability of new options such as single-use negative pressure wound therapy is advancing the use potential.

The market is also expected to gain from the development and launch of sophisticated NPWT devices that are user friendly. While NPWT pumps are advancing, even wound dressings are evolving such as antimicrobial contact layers and incisional management dressings. The introduction of affordable disposable NPWT by leading companies and rising awareness of this among people is likely to drive market gains.

Conventional, one of the segments analyzed in the report, is projected to grow at a 5.7% CAGR to reach US$2.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Single-Use segment is readjusted to a revised 7.1% CAGR for the next 7-year period.

This segment currently accounts for a 28.4% share of the global Negative Pressure Wound Therapy (NPWT) market. While conventional devices lead the market, these systems are for use in hospitals and are not appropriate for homecare settings, as they entail the usage of bulky canisters. Such devices can be purchased and also rented, which is anticipated to augment NPWT usage in developing countries.

Single use NPWT is likely to register strong growth owing to their suitability for use in homecare settings. The growing trend of patient transition to home care settings in Europe and North America is therefore expected to drive their demand. Further, the advantages offered by single use NPWT such as battery based pump, appropriateness for treating moderate to low exuding wounds, lower cost, and their growing availability in the market are also fueling their adoption.

The U.S. Market is Estimated at $1.2 Billion in 2022, While China is Forecast to Reach $189.7 Million by 2026

The Negative Pressure Wound Therapy (NPWT) market in the U.S. is estimated at US$1.2 Billion in the year 2022. The country currently accounts for a 51.6% share in the global market. China , the world's second largest economy, is forecast to reach an estimated market size of US$189.7 Million in the year 2026 trailing a CAGR of 9.6% through the analysis period.

Among the other noteworthy geographic markets are Japan and Canada , each forecast to grow at 4.3% and 6.3% respectively over the analysis period. Within Europe , Germany is forecast to grow at approximately 5.6% CAGR while Rest of European market (as defined in the study) will reach US$124 Million by the close of the analysis period.

North America is a key NPWT devices market, supported by the rising number of acute wound cases and the significant cost of treatment in the US, and easy device availability. Further, the expanding pool of burn patients and patients having pressure ulcers and diabetic foot ulcers on account of rising incidence of diabetes and obesity, are also fueling growth of the market.

Increase in geriatric population who generally are vulnerable to various health conditions such as diabetes is also a providing a boost to the market. The NPWT devices market in APAC is anticipated to record strong growth, attributed to the rising incidence of chronic diseases, and the increasing number of people suffering from acute wounds.

Global competitiveness and key competitor percentage market shares

Market presence across multiple geographies - Strong/Active/Niche/Trivial

Online interactive peer-to-peer collaborative bespoke updates

Access to the publisher's digital archives and Research Platform

Complimentary updates for one year

COVID-19-Led Delay in Wound Care: The Dire Picture & Efforts to Improve Outcomes

Pandemic Shifts Focus to Home-Based Wound Care

Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2022 (E)

Wound & Wound Management: A Prelude

What is Negative Pressure Wound Therapy (NPWT)?

Negative Pressure Wound Therapy: Indications and Contraindications

Factors Driving Progression of Negative Pressure Wound Therapy

Single Use NPWT Experience Strong Growth Bolstered by Inherent Attributes and Increased Shifting of Wound care to Home Care Settings

2. FOCUS ON SELECT PLAYERS (Total 54 Featured)

ATMOS MedizinTechnik GmbH & Co. KG

Lohmann & Rauscher GmbH & Co. KG

Growing Emphasis on Preventive Wound Healing Bodes Well for NPWT Market

Rise in Caesarean Section Procedures Spurs Post-Operative Use of NPWT Devices

Technological Advancements and New Product Launches Crucial to Sustain Future Growth

Advancements in Foams and Dressings Extend NPWT Application to Outpatient Settings

Hybrid Negative Pressure Wound Therapy (hNPWT) Widens Growth Prospects

NPWTi-d Takes Negative Pressure Wound Therapy to Next Level with Cost Benefits

Rising Incidence of Chronic Wounds and Increasing HealthCare Burden Catalyze Growth Prospects

How NPWT Aids in Healing of Acute Wounds

Rise in Prevalence of Pressure Ulcers to Drive Growth

Global Epidemics of Diabetes and Increasing Incidence of DFUs to Propel Market Growth

Aging Population: A Strong Growth Driver

For more information about this report visit https://www.researchandmarkets.com/r/4u4wve

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/global-negative-pressure-wound-therapy-npwt-market-report-2022-market-to-reach-3-1-billion-by-2026---hybrid-negative-pressure-wound-therapy-hnpwt-widens-growth-prospects-301552006.html

Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VistaGen Therapeutics Inc (NASDAQ: VTGN) has announced topline results from its PALISADE-1 Phase 3 trial of PH94B for the acute treatment of social anxiety disorder. PH94B did not achieve its primary endpoint, as measured by change from baseline using the Subjective Units of Distress Scale (SUDS) compared to placebo. SUDS rating scale is used to measure the intensity of distress or nervousness in people with social anxiety. Social anxiety disorder affects an estimated 25 million Americans. Altho

Q.: My wife inherited a 401(k) from my mom who died recently. Assuming this is a traditional 401(k), you are correct that whatever comes out of the account will be likely be taxable to you. Transfer your wife’s share of the money to an Inherited 401(k) with the company that held your mom’s 401(k).

Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.

Yahoo Finance's Ines Ferré breaks down how stocks are trading on Friday afternoon as the Nasdaq lags following Snap earnings.

Yahoo Finance's Brian Cheung and Akiko Fujita discuss Snap earnings and analyst reratings on the stock.

In this article, we discuss the 10 stocks to buy before their earnings reports. If you want to read about some more stocks expected to gain following their quarterly results, go directly to 5 Stocks to Buy Before Their Earnings Reports. With the inflation in the US at a 40-year high and the Federal Reserve […]

When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).

(Bloomberg) -- Trevor Milton was riding high a little over two years ago. His battery-electric and fuel cell-powered truck startup, Nikola Corp., had just gone public by merging with a special purpose acquisition company, and its shares were among the first post-SPAC meme stocks to go berserk. Without having sold a single truck, Nikola briefly exceeded Ford Motor Co. in market value.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recal

Fewer are reverting to traditional office jobs, with a growing number seeking nontraditional roles, or even the opportunity to start a new business.

IBM (IBM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.

Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.

Yahoo Finance anchors discuss three other business stories, including Buzz Aldrin auctioning off his moon landing jacket, Tesla getting its own lane at the Mexican border, and Disney adding R-rated movies to its streaming service.

(Bloomberg) -- Verizon Communications Inc. shares careened toward their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal T

Ford and Cleveland-Cliffs are exposed to severe systemic risk

When a company creates a significant amount of value over the long term, its stock price generally delivers strong gains. To bring their shares back into easier reach for retail investors, companies can conduct stock splits, and in 2022, a host of big technology companies are doing just that. Google parent Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) was the most recent.

Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.

Jim Cramer is a lightning rod when it comes to scrutiny. On one hand, giving investing advice every day on air for years is naturally going to produce some losing picks. However, Cramer has become the focal point of a lot of targeted opposition. For instance, you can check out his ongoing (albeit one-sided) feud with George Noble, who is quick to call out Cramer. Or, you could check out the Journal of Retirement’s in-depth study of Cramer’s Charitable Trust performance and see that “Cramer’s por

The average of price targets set by Wall Street analysts indicates a potential upside of 38.9% in Devon Energy (DVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.